BCK Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

BCK Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-17,500	Closed	-$1.26M	–	162
2020 Q4	$1.26M	Buy	+17,500	New	+$916K	1.01%	32

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

BCK Capital Management's BEAT Position: Q1 2021 in Review

BCK Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 17,500 shares — an estimated $1.26M sold.

BCK Capital Management first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $1.26M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

BCK Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
BCK Capital Management sold 17,500 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.26M.
BCK Capital Management first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
BCK Capital Management's BioTelemetry, Inc. position peaked at $1.26M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on BCK Capital Management's 13F filing for Q1 2021, filed 6 May 2021.